These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 348205)

  • 21. [Action of actodigin (AY-22,241) in patients with cardiac insufficiency and chronic auricular fibrillation or flutter].
    Bojorges R; Cárdenas M; Pastelín G; Mendez R
    Arch Inst Cardiol Mex; 1974; 44(4):615-23. PubMed ID: 4847978
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cardiac glycosides in complex treatment of patients with heart failure and supraventricular arrhythmias].
    Zamotaev IuN; Kremnev IuA; Podshibiakin SE
    Klin Med (Mosk); 2005; 83(7):59-63. PubMed ID: 16117429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The influence of doxepin on the efficiancy of the human heart (author's transl)].
    Wolter H; Klepzig H; Frisch P
    Med Klin; 1977 Sep; 72(35):1392-401. PubMed ID: 333252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative hemodynamic studies on various heart glycosides].
    Gotsch K; Klein WW; Leb G; Pavek P; Passath A
    Z Kreislaufforsch; 1972 Jul; 61(7):577-87. PubMed ID: 5055577
    [No Abstract]   [Full Text] [Related]  

  • 25. [Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].
    Mitrovic V; Neuzner J; Opper H; Thormann J; Schlepper M
    Z Kardiol; 1994; 83 Suppl 2():37-48. PubMed ID: 8091823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical use of a new cardioactive glycoside: proscillaridin A. Case studies].
    Pagliara R
    Minerva Med; 1967 Dec; 58(96):4296-301. PubMed ID: 6081717
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacokinetic-pharmacodynamic interrelationships of intravenous and oral levosimendan in patients with severe congestive heart failure.
    Põder P; Eha J; Sundberg S; Antila S; Heinpalu M; Loogna I; Planken U; Rantanen S; Lehtonen L
    Int J Clin Pharmacol Ther; 2003 Aug; 41(8):365-73. PubMed ID: 12940594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of ibutilide in patients with heart failure due to left ventricular systolic dysfunction.
    Tisdale JE; Overholser BR; Sowinski KM; Wroblewski HA; Amankwa K; Borzak S; Kingery JR; Coram R; Zipes DP; Flockhart DA; Kovacs RJ
    Pharmacotherapy; 2008 Dec; 28(12):1461-70. PubMed ID: 19025427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First clinical trial with etomoxir in patients with chronic congestive heart failure.
    Schmidt-Schweda S; Holubarsch C
    Clin Sci (Lond); 2000 Jul; 99(1):27-35. PubMed ID: 10887055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effect of beta-receptor blockers and cardiac glycosides on the heart rate, systolic blood pressure and ST interval in submaximal ergometer exertion].
    Schaller K; Lange S
    Z Gesamte Inn Med; 1982 Jan; 37(2):50-3. PubMed ID: 7080551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Studies on the effect of peruvoside on heart function in animal experiments].
    Schorscher E; Sommer S; Wild AJ; Block A
    Arzneimittelforschung; 1968 Dec; 18(12):1582-90. PubMed ID: 5756257
    [No Abstract]   [Full Text] [Related]  

  • 32. The role of the sugar component in cardiac glycosides on their action in patients with auricular fibrillation and congestive failure.
    Gold H; Kwit NT; Shane SJ; Dayrit C
    J Clin Pharmacol J New Drugs; 1969; 9(3):148-54. PubMed ID: 5255179
    [No Abstract]   [Full Text] [Related]  

  • 33. [Contribution to the konwledge of some effects of proscillaridin on the cardiovascular system. Electrocardiographic and radiocardiographic research].
    Sorrentino F; Musco A; Cascone O; Modica G
    Clin Ter; 1966 Jul; 38(1):39-48. PubMed ID: 5990470
    [No Abstract]   [Full Text] [Related]  

  • 34. Contrasting effect on cardiac output of digoxin and gitoxin in humans during congestive heart failure.
    Col J; Wijns W; Brasseur L; Lesne M
    Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):314-8. PubMed ID: 7263109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The clinical use of a new cardioactive glycoside: proscillaridin A].
    Maiorano G; Arbore S
    Minerva Med; 1967 Dec; 58(96):4243-6. PubMed ID: 6083285
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical trial of a new cardiac glycoside: cd.412].
    Gentile C; Gentile JH
    Prensa Med Argent; 1972 Jun; 59(22):841-8. PubMed ID: 5051118
    [No Abstract]   [Full Text] [Related]  

  • 37. Multicenter studies of 2% nitroglycerin ointment in patients with heart failure.
    Kawai C; Kambara H; Nakano T; Hirota Y; Saito M; Kagoshima T; Nobuyoshi M; Tsuruha Y
    Clin Ther; 1984; 6(5):677-88. PubMed ID: 6434184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cardiotonic effect of Cd 412 (Peruvosid) on normal humans and subjects with cardiac insufficiency].
    Rivara Ruiz G; Dejo Bustios G; Alvarez Molteni R
    Rev Esp Cardiol; 1971; 24(2):191-9. PubMed ID: 4944701
    [No Abstract]   [Full Text] [Related]  

  • 39. [Evaluation of a pyridopyridazine as a drug with marked antihypertensive properties (author's transl)].
    Lehmann HU; Witt E; Hochrein H
    Med Klin; 1977 Jul; 72(28-29):1203-8. PubMed ID: 887046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical action of a new cardioactive glycoside: proscillaridin A].
    Facci M
    Minerva Med; 1967 Dec; 58(96):4276-86. PubMed ID: 6083289
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.